AtriCure Company Profile (NASDAQ:ATRC)

About AtriCure

AtriCure logoAtriCure, Inc. is a medical device company providing atrial fibrillation (Afib) solutions. The Company's segment develops, manufactures, and sells devices designed primarily for the surgical ablation of cardiac tissue and systems designed for the exclusion of the left atrial appendage. The Company has various product lines for the ablation of cardiac tissue, including its Isolator Synergy Ablation System, for the treatment of persistent and longstanding persistent forms of Afib in patients undergoing certain open concomitant procedures. Its Isolator Synergy System, which includes its Isolator Synergy clamps, radio frequency (RF) generator and related switchbox, provides treatment for persistent and long-standing persistent Afib concomitant. It has two primary product lines for cardiac tissue ablation, which include Radio Frequency Ablation Devices and cryoICE Cryoablation System, and a product line for left atrial appendage exclusion.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: ATRC
  • CUSIP: 04963C20
Key Metrics:
  • Previous Close: $14.58
  • 50 Day Moving Average: $15.00
  • 200 Day Moving Average: $15.60
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -16.94
  • P/E Growth: -0.64
  • Market Cap: $489.40M
  • Outstanding Shares: 33,202,000
  • Beta: 0.91
Additional Links:
Companies Related to AtriCure:

Analyst Ratings

Consensus Ratings for AtriCure (NASDAQ:ATRC) (?)
Ratings Breakdown: 8 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $20.71 (40.53% upside)

Analysts' Ratings History for AtriCure (NASDAQ:ATRC)
Show:
DateFirmActionRatingPrice TargetDetails
8/10/2016BTIG ResearchReiterated RatingBuy$34.00 -> $19.00View Rating Details
8/8/2016Needham & Company LLCReiterated RatingBuy$23.00 -> $20.00View Rating Details
8/8/2016Piper Jaffray Cos.Reiterated RatingOverweight$22.00 -> $17.00View Rating Details
8/6/2016Canaccord GenuitySet Price TargetBuy$21.00View Rating Details
8/6/2016JMP SecuritiesSet Price TargetBuy$23.00View Rating Details
8/5/2016Stifel NicolausLower Price TargetBuy$26.00 -> $21.00View Rating Details
3/29/2016Northland SecuritiesInitiated CoverageOutperform$24.00View Rating Details
10/6/2015Leerink SwannReiterated RatingBuyView Rating Details
7/28/2015Dougherty & CoBoost Price TargetBuy$25.00 -> $30.00View Rating Details
(Data available from 8/29/2014 forward)

Earnings

Earnings History for AtriCure (NASDAQ:ATRC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/25/2016        
8/4/2016Q216($0.30)($0.26)$39.84 million$39.70 millionViewListenView Earnings Details
4/28/2016Q116($0.32)($0.31)$36.08 million$35.90 millionViewListenView Earnings Details
2/23/2016Q415($0.36)($0.36)$35.90 million$35.90 millionViewListenView Earnings Details
10/27/2015Q315($0.22)($0.22)$31.32 million$31.40 millionViewListenView Earnings Details
7/28/2015Q215($0.21)($0.18)$30.51 million$32.58 millionViewListenView Earnings Details
4/29/2015Q115($0.21)($0.19)$28.65 million$29.90 millionViewListenView Earnings Details
2/23/2015Q414($0.20)($0.20)$28.40 million$29.40 millionViewListenView Earnings Details
10/30/2014Q314($0.17)($0.02)$25.60 million$26.70 millionViewListenView Earnings Details
7/24/2014Q214($0.19)($0.10)$25.03 million$26.51 millionViewListenView Earnings Details
4/24/2014Q114($0.22)($0.31)$23.36 million$24.80 millionViewListenView Earnings Details
2/27/2014Q413($0.14)($0.24)$21.16 million$21.90 millionViewListenView Earnings Details
10/29/2013Q313($0.15)($0.13)$18.30 million$20.10 millionViewListenView Earnings Details
8/1/2013Q2 2013($0.10)($0.09)$19.42 million$20.40 millionViewListenView Earnings Details
5/2/2013Q1 2013($0.09)($0.10)$18.63 million$19.43 millionViewListenView Earnings Details
2/28/2013Q4 2012($0.09)($0.12)$18.46 million$18.40 millionViewListenView Earnings Details
11/1/2012Q312($0.11)($0.16)$17.29 million$16.10 millionViewN/AView Earnings Details
8/2/2012($0.07)($0.08)ViewN/AView Earnings Details
5/2/2012($0.13)($0.10)ViewN/AView Earnings Details
11/1/2011($0.07)($0.07)ViewN/AView Earnings Details
8/2/2011($0.01)($0.06)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for AtriCure (NASDAQ:ATRC)
Current Year EPS Consensus Estimate: $-1.16 EPS
Next Year EPS Consensus Estimate: $-0.87 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163($0.33)($0.27)($0.30)
Q2 20162($0.31)($0.29)($0.30)
Q3 20162($0.32)($0.30)($0.31)
Q4 20162($0.34)($0.28)($0.31)
Q1 20171($0.25)($0.25)($0.25)
Q2 20171($0.26)($0.26)($0.26)
Q3 20171($0.21)($0.21)($0.21)
Q4 20171($0.20)($0.20)($0.20)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for AtriCure (NASDAQ:ATRC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for AtriCure (NASDAQ:ATRC)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/17/2016Elizabeth D KrellDirectorSell5,000$15.20$76,000.00View SEC Filing  
3/8/2016Elizabeth D KrellDirectorSell10,000$16.91$169,100.00View SEC Filing  
12/3/2015Douglas J. SeithCOOSell5,000$21.55$107,750.00View SEC Filing  
12/2/2015Elizabeth D. KrellDirectorSell10,000$21.88$218,800.00View SEC Filing  
11/11/2015Elizabeth D. KrellDirectorSell10,000$20.68$206,800.00View SEC Filing  
4/1/2015Michael D HoovenDirectorSell142,268$20.81$2,960,597.08View SEC Filing  
3/31/2015Michael D HoovenDirectorSell20,000$20.51$410,200.00View SEC Filing  
3/30/2015Michael D HoovenDirectorSell85,000$21.01$1,785,850.00View SEC Filing  
3/13/2015Karen P RobardsDirectorSell3,150$19.53$61,519.50View SEC Filing  
3/5/2015Douglas J SeithCOOSell36,688$17.51$642,406.88View SEC Filing  
3/2/2015Elizabeth D KrellDirectorSell10,000$17.63$176,300.00View SEC Filing  
5/6/2014Douglas SeithSVPBuy1,000$15.04$15,040.00View SEC Filing  
9/13/2013Richard JohnstonInsiderSell77,610$10.00$776,100.00View SEC Filing  
8/12/2013Douglas SeithSVPBuy10,000$9.58$95,800.00View SEC Filing  
8/5/2013Richard JohnstonInsiderSell20,047$10.00$200,470.00View SEC Filing  
7/11/2013Richard M JohnstonInsiderSell2,343$10.00$23,430.00View SEC Filing  
6/19/2013Richard M JohnstonInsiderSell29,348$8.96$262,958.08View SEC Filing  
6/18/2013Richard M JohnstonInsiderSell39,682$9.18$364,280.76View SEC Filing  
6/14/2013Richard M JohnstonInsiderSell95,598$8.97$857,514.06View SEC Filing  
6/12/2013Richard M JohnstonInsiderSell35,372$9.01$318,701.72View SEC Filing  
3/6/2013James L LuckyVPSell50,065$8.14$407,529.10View SEC Filing  
9/14/2012Mark R LanningDirectorBuy11,006$7.64$84,085.84View SEC Filing  
9/13/2012Michael D HoovenDirectorBuy1,110$7.37$8,180.70View SEC Filing  
9/12/2012Michael D HoovenDirectorBuy1,150$7.10$8,165.00View SEC Filing  
9/11/2012Michael D HoovenDirectorBuy1,145$7.18$8,221.10View SEC Filing  
9/10/2012Michael D HoovenDirectorBuy1,215$7.15$8,687.25View SEC Filing  
9/7/2012Michael D HoovenDirectorBuy1,215$6.88$8,359.20View SEC Filing  
8/23/2012Karen P RobardsDirectorBuy1,000$6.70$6,700.00View SEC Filing  
8/16/2012Karen P RobardsDirectorBuy1,000$6.98$6,980.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for AtriCure (NASDAQ:ATRC)
DateHeadline
finance.yahoo.com logoAtriCure to Present at the Morgan Stanley Global Healthcare Conference (NASDAQ:ATRC)
finance.yahoo.com - August 18 at 9:05 PM
capitalcube.com logoAtriCure, Inc. breached its 50 day moving average in a Bullish Manner : ATRC-US : August 15, 2016 (NASDAQ:ATRC)
www.capitalcube.com - August 15 at 10:51 AM
capitalcube.com logoETF’s with exposure to AtriCure, Inc. : August 11, 2016 (NASDAQ:ATRC)
www.capitalcube.com - August 11 at 12:52 PM
capitalcube.com logoAtriCure, Inc. :ATRC-US: Earnings Analysis: Q2, 2016 By the Numbers : August 10, 2016 (NASDAQ:ATRC)
www.capitalcube.com - August 10 at 4:00 PM
finance.yahoo.com logoEdited Transcript of ATRC earnings conference call or presentation 4-Aug-16 8:30pm GMT (NASDAQ:ATRC)
finance.yahoo.com - August 7 at 8:17 AM
News IconAtriCure shares dip despite Street-beating Q2 (NASDAQ:ATRC)
www.massdevice.com - August 5 at 9:01 PM
streetinsider.com logoNeedham & Company Cuts Price Target on AtriCure (ATRC) to $20; Reiterates Buy (NASDAQ:ATRC)
www.streetinsider.com - August 5 at 3:39 PM
twst.com logoAtriCure Inc.: AtriCure Reports Second Quarter 2016 Financial Results (NASDAQ:ATRC)
www.twst.com - August 4 at 9:24 PM
tmcnet.com logoAtriCure Reports Second Quarter 2016 Financial Results (NASDAQ:ATRC)
www.tmcnet.com - August 4 at 9:24 PM
sg.finance.yahoo.com logoAtriCure reports 2Q loss (NASDAQ:ATRC)
sg.finance.yahoo.com - August 4 at 9:24 PM
biz.yahoo.com logoQ2 2016 AtriCure Inc Earnings Release - After Market Close (NASDAQ:ATRC)
biz.yahoo.com - August 4 at 12:09 PM
publicnow.com logoAtriCure to Present at the Canaccord Genuity Growth Conference (NASDAQ:ATRC)
www.publicnow.com - July 22 at 6:08 PM
globenewswire.com logoBioSig Technologies Issues Shareholder Letter (NASDAQ:ATRC)
globenewswire.com - July 19 at 9:49 AM
publicnow.com logoAtriCure to Announce Second Quarter 2016 Financial Results (NASDAQ:ATRC)
www.publicnow.com - July 11 at 4:23 PM
capitalcube.com logoAtriCure, Inc. breached its 50 day moving average in a Bullish Manner : ATRC-US : July 7, 2016 (NASDAQ:ATRC)
www.capitalcube.com - July 7 at 8:09 AM
4-traders.com logoAtriCure : Receives CE Mark for the AtriClip® PRO2 Device (NASDAQ:ATRC)
www.4-traders.com - July 1 at 11:40 AM
publicnow.com logoAtriCure Receives CE Mark for the AtriClip® PRO2 Device (NASDAQ:ATRC)
www.publicnow.com - June 29 at 8:21 AM
4-traders.com logoAtriCure : Announces the First Patient Enrolled in the FROST Cryoanalgesia Study (NASDAQ:ATRC)
www.4-traders.com - June 22 at 3:39 PM
finance.yahoo.com logoAtriCure Announces the First Patient Enrolled in the FROST Cryoanalgesia Study (NASDAQ:ATRC)
finance.yahoo.com - June 21 at 8:00 AM
capitalcube.com logoAtriCure, Inc. breached its 50 day moving average in a Bearish Manner : ATRC-US : June 20, 2016 (NASDAQ:ATRC)
www.capitalcube.com - June 20 at 8:15 AM
feeds.reuters.com logoBRIEF-AtriCure files for mixed shelf offering of up to $150 mln (NASDAQ:ATRC)
feeds.reuters.com - June 17 at 1:16 PM
bizjournals.com logoSeveral Ohio companies named to ‘Most Trustworthy’ list (NASDAQ:ATRC)
www.bizjournals.com - June 15 at 6:25 AM
capitalcube.com logoAtriCure, Inc. – Value Analysis (NASDAQ:ATRC) : June 9, 2016 (NASDAQ:ATRC)
www.capitalcube.com - June 9 at 1:39 PM
capitalcube.com logoAtriCure, Inc. breached its 50 day moving average in a Bullish Manner : ATRC-US : June 8, 2016 (NASDAQ:ATRC)
www.capitalcube.com - June 8 at 8:10 AM
biz.yahoo.com logoATRICURE, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of Secu (NASDAQ:ATRC)
biz.yahoo.com - May 27 at 2:34 PM
News IconEarnings Review and Stock Rundown for AtriCure, Inc. (NASDAQ:ATRC) - Wall Street Hints and News (NASDAQ:ATRC)
hintsnewsnetwork.com - May 26 at 9:50 AM
investornewswire.com logoAtriCure, Inc. (NASDAQ:ATRC) Impact Score At 50 - Investor Newswire (NASDAQ:ATRC)
www.investornewswire.com - May 24 at 6:37 PM
News IconAfter Last Week What Do Analysts Think Of AtriCure, Inc. (ATRC) - Share Trading News (NASDAQ:ATRC)
www.sharetrading.news - May 22 at 11:06 PM
equities.com logoAtriCure Inc. (ATRC) Hits New 52-week Low During May 12 Session - Equities.com (NASDAQ:ATRC)
www.equities.com - May 13 at 11:57 PM
News IconConsensus Rating Review for AtriCure, Inc. (NASDAQ:ATRC) - B.O.D.Y Confidential (NASDAQ:ATRC)
www.bodyconfidential.com - May 10 at 6:48 PM
thestreet.com logoAtriCure Becomes Oversold (ATRC) (NASDAQ:ATRC)
www.thestreet.com - May 6 at 6:47 PM
finance.yahoo.com logoATRICURE, INC. Financials (NASDAQ:ATRC)
finance.yahoo.com - May 6 at 1:04 PM
equities.com logoAtriCure Inc. (ATRC) Hits New 52-week Low During May 04 Session - Equities.com (NASDAQ:ATRC)
www.equities.com - May 6 at 12:16 AM
equities.com logoAtriCure Inc. (ATRC) Hits New 52-week Low During May 03 Session - Equities.com (NASDAQ:ATRC)
www.equities.com - May 4 at 11:55 PM
capitalcube.com logoAtriCure, Inc. :ATRC-US: Earnings Analysis: Q1, 2016 By the Numbers (NASDAQ:ATRC)
www.capitalcube.com - May 4 at 1:24 PM
equities.com logoAtriCure Inc. (ATRC) is Trading Lower on Unusual Volume for May 02 - Equities.com (NASDAQ:ATRC)
www.equities.com - May 4 at 12:02 AM
equities.com logoAtriCure Inc. (ATRC) Hits New 52-week Low During May 02 Session - Equities.com (NASDAQ:ATRC)
www.equities.com - May 4 at 12:02 AM
News IconAverage Analyst Rating for AtriCure, Inc. (NASDAQ:ATRC) - B.O.D.Y Confidential (NASDAQ:ATRC)
www.bodyconfidential.com - May 3 at 6:50 PM
equities.com logoAtriCure Inc. (ATRC) Drops 6.29% on May 02 - Equities.com (NASDAQ:ATRC)
www.equities.com - May 3 at 6:50 PM
capitalcube.com logoETF’s with exposure to AtriCure, Inc. : May 3, 2016 (NASDAQ:ATRC)
www.capitalcube.com - May 3 at 1:36 PM
thestreet.com logoAtriCure Suffers From Weak Chart, Downgrade (NASDAQ:ATRC)
realmoney.thestreet.com - May 3 at 12:10 PM
kcregister.com logoStock Runners: AtriCure, Inc. (NASDAQ:ATRC), Perrigo Company plc Ordinary Shares (NYSE:PRGO), Mitsubishi UFJ ... - KC Register (NASDAQ:ATRC)
www.kcregister.com - May 2 at 7:08 PM
publicnow.com logoAtriCure to Present at the UBS Global Healthcare Conference (NASDAQ:ATRC)
www.publicnow.com - May 2 at 4:20 PM
capitalcube.com logoAtriCure, Inc. breached its 50 day moving average in a Bearish Manner : ATRC-US : May 2, 2016 (NASDAQ:ATRC)
www.capitalcube.com - May 2 at 8:14 AM
News IconShare Performance and Target Price Review AtriCure, Inc. (NASDAQ:ATRC) - B.O.D.Y Confidential (NASDAQ:ATRC)
www.bodyconfidential.com - April 29 at 6:54 PM
finance.yahoo.com logoEdited Transcript of ATRC earnings conference call or presentation 28-Apr-16 8:30pm GMT (NASDAQ:ATRC)
finance.yahoo.com - April 29 at 3:33 PM
biz.yahoo.com logoATRICURE, INC. Files SEC form 10-Q, Quarterly Report (NASDAQ:ATRC)
biz.yahoo.com - April 29 at 11:43 AM
thestreet.com logoPeek Under The Hood: XHE Has 10% Upside (NASDAQ:ATRC)
www.thestreet.com - April 28 at 7:11 PM
biz.yahoo.com logoAtriCure Inc Earnings Call scheduled for 4:30 pm ET today (NASDAQ:ATRC)
biz.yahoo.com - April 28 at 4:30 PM
finance.yahoo.com logo4:02 pm AtriCure amended and restated term loan and revolving line of credit agreement; provides access to a new $25 mln five-year term loan as well as renewing a $15 mln revolving line of credit (NASDAQ:ATRC)
finance.yahoo.com - April 28 at 4:02 PM

Social

AtriCure (NASDAQ:ATRC) Chart for Monday, August, 29, 2016


Last Updated on 8/29/2016 by MarketBeat.com Staff